Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cardiovascular effects of histone deacetylase inhibitors epigenetic therapies: Systematic review of 62 studies and new hypotheses for future research.

× No keyword cloud information.

12 in total

1. Changes in cardiac Nav1.5 expression, function, and acetylation by pan-histone deacetylase inhibitors.

Authors: Qin Xu; Dakshesh Patel; Xian Zhang; Richard D Veenstra
Journal: Am J Physiol Heart Circ Physiol Date: 2016-09-16 Impact factor: 4.733

Review 2. The nonepigenetic role for small molecule histone deacetylase inhibitors in the regulation of cardiac function.

Authors: Samantha S Romanick; Bradley S Ferguson
Journal: Future Med Chem Date: 2019-06-04 Impact factor: 3.808

3. Artificial intelligence opportunities in cardio-oncology: Overview with spotlight on electrocardiography.

Authors: Daniel Sierra-Lara Martinez; Peter A Noseworthy; Oguz Akbilgic; Joerg Herrmann; Kathryn J Ruddy; Abdulaziz Hamid; Ragasnehith Maddula; Ashima Singh; Robert Davis; Fatma Gunturkun; John L Jefferies; Sherry-Ann Brown
Journal: Am Heart J Plus Date: 2022-04-01

4. Histone deacetylase 6 selective inhibitor ACY1215 inhibits cell proliferation and enhances the chemotherapeutic effect of 5-fluorouracil in HCT116 cells.

Authors: Yuyong Tan; Shilan Zhang; Hongyi Zhu; Yi Chu; Hejun Zhou; Deliang Liu; Jirong Huo
Journal: Ann Transl Med Date: 2019-01

Review 5. Epigenomic and transcriptomic approaches in the post-genomic era: path to novel targets for diagnosis and therapy of the ischaemic heart? Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart.

Authors: Cinzia Perrino; Albert-Laszló Barabási; Gianluigi Condorelli; Sean Michael Davidson; Leon De Windt; Stefanie Dimmeler; Felix Benedikt Engel; Derek John Hausenloy; Joseph Addison Hill; Linda Wilhelmina Van Laake; Sandrine Lecour; Jonathan Leor; Rosalinda Madonna; Manuel Mayr; Fabrice Prunier; Joost Petrus Geradus Sluijter; Rainer Schulz; Thomas Thum; Kirsti Ytrehus; Péter Ferdinandy
Journal: Cardiovasc Res Date: 2017-06-01 Impact factor: 10.787

Review 6. The role of post-translational modifications in cardiac hypertrophy.

Authors: Kaowen Yan; Kun Wang; Peifeng Li
Journal: J Cell Mol Med Date: 2019-04-04 Impact factor: 5.310

Review 7. Regulation of Chemokines and Cytokines by Histone Deacetylases and an Update on Histone Decetylase Inhibitors in Human Diseases.

Authors: Himavanth Reddy Gatla; Nethaji Muniraj; Prashanth Thevkar; Siddhartha Yavvari; Sahithi Sukhavasi; Monish Ram Makena
Journal: Int J Mol Sci Date: 2019-03-05 Impact factor: 5.923

8. Differences in Functional Expression of Connexin43 and Na_V1.5 by Pan- and Class-Selective Histone Deacetylase Inhibition in Heart.

Authors: Xian Zhang; Dakshesh Patel; Qin Xu; Richard Veenstra
Journal: Int J Mol Sci Date: 2018-08-04 Impact factor: 5.923

Review 9. Histone Deacetylase Inhibitors as Multitarget-Directed Epi-Drugs in Blocking PI3K Oncogenic Signaling: A Polypharmacology Approach.

Authors: Kasturi Ranganna; Chelliah Selvam; Amruthesh Shivachar; Zivar Yousefipour
Journal: Int J Mol Sci Date: 2020-11-02 Impact factor: 5.923

Review 10. Human iPSC-Cardiomyocytes as an Experimental Model to Study Epigenetic Modifiers of Electrophysiology.

Authors: Maria R Pozo; Gantt W Meredith; Emilia Entcheva
Journal: Cells Date: 2022-01-07 Impact factor: 7.666

Cardiovascular effects of histone deacetylase inhibitors epigenetic therapies: Systematic review of 62 studies and new hypotheses for future research.